Cardio-Oncology

Scope & Guideline

Uniting Disciplines: Elevating Cardiovascular Care in Cancer Treatment

Introduction

Delve into the academic richness of Cardio-Oncology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCARDIO-ONCOLOGY / Cardio-Oncol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal "Cardio-Oncology" focuses on the intersection of cardiovascular health and cancer treatment, addressing the unique challenges faced by cancer patients who are at risk for cardiac complications due to their therapies. This journal aims to disseminate research that improves understanding, prevention, and management of cardiotoxicity in cancer patients.
  1. Cardiac Toxicity Assessment and Management:
    Research articles frequently explore the assessment and management of cardiac toxicity induced by various cancer therapies, including chemotherapy and immunotherapy. This includes studies on biomarkers, imaging techniques, and clinical interventions.
  2. Cardiovascular Risks Associated with Cancer Treatments:
    The journal addresses the cardiovascular risks associated with cancer treatments, such as immune checkpoint inhibitors and traditional chemotherapy agents. It provides insights into the mechanisms by which these therapies affect cardiac function and overall patient health.
  3. Innovative Therapeutic Approaches:
    There is a consistent emphasis on innovative therapeutic strategies aimed at preventing or mitigating cardiotoxicity. This includes studies on cardioprotective agents, lifestyle interventions, and rehabilitation programs tailored for cancer survivors.
  4. Multidisciplinary Care Models:
    The journal promotes the development of multidisciplinary care models that integrate cardiology and oncology, aiming to enhance patient outcomes through collaborative approaches in managing cancer and cardiovascular health.
  5. Epidemiological and Clinical Studies:
    Epidemiological studies that analyze the incidence and outcomes of cardiovascular complications in cancer patients are a core feature, providing essential data to guide clinical practice.
The journal has been actively publishing on several trending and emerging themes within the field of cardio-oncology, reflecting the evolving landscape of cancer treatment and its cardiovascular implications.
  1. Integration of Telehealth in Cardio-Oncology:
    Recent publications emphasize the role of telehealth in managing cardio-oncology patients, particularly in the context of rehabilitation and monitoring, which has gained importance due to the COVID-19 pandemic.
  2. Cardiometabolic Health in Cancer Survivors:
    There is an increasing focus on the cardiometabolic health of cancer survivors, highlighting the interplay between cancer therapies, cardiovascular health, and metabolic syndrome, which is crucial for long-term management.
  3. Immune Checkpoint Inhibitor-Associated Cardiotoxicity:
    Research on the cardiotoxic effects of immune checkpoint inhibitors is rapidly emerging, as these therapies become more widely used, necessitating a better understanding of their cardiovascular impacts.
  4. Use of Biomarkers for Predicting Cardiotoxicity:
    The exploration of novel biomarkers for predicting cardiotoxicity from cancer therapies is a growing trend, with studies focusing on genetic, proteomic, and inflammatory markers that could facilitate earlier detection and intervention.
  5. Patient-Centered Care and Shared Decision Making:
    There is a notable trend towards incorporating patient-centered care and shared decision-making frameworks in cardio-oncology, emphasizing the importance of patient preferences and experiences in treatment planning.

Declining or Waning

While the journal has a strong focus on emerging trends in cardio-oncology, certain topics appear to be declining in prominence. This may reflect shifts in research interests or advancements in clinical practices.
  1. Traditional Cardiac Monitoring Techniques:
    There is a noticeable decrease in studies focusing solely on traditional cardiac monitoring techniques, such as standard echocardiography, as newer imaging modalities and biomarkers gain popularity for their predictive capabilities.
  2. Case Reports of Rare Cardiac Events:
    The frequency of case reports detailing rare cardiac events related to specific cancer treatments has diminished, possibly due to an increased focus on larger cohort studies and systematic reviews that provide broader insights.
  3. Basic Research on Cardiac Physiology:
    Research exploring basic cardiac physiology without a direct link to cancer therapies has seen a decline, as the journal increasingly prioritizes studies that directly relate to clinical outcomes and interventions relevant to patients undergoing cancer treatment.

Similar Journals

American Heart Journal Plus: Cardiology Research and Practice

Innovating Cardiovascular Health Solutions
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

American Heart Journal Plus: Cardiology Research and Practice, published by Elsevier, is a prominent open-access platform dedicated to advancing knowledge in the field of cardiology. With an evolving ISSN of 2666-6022, this journal serves as a vital resource for cardiologists, researchers, and healthcare professionals, contributing to the ever-growing discourse surrounding cardiovascular health. With a mission to disseminate high-quality research and innovative practices from 2021 to 2024, it aims to bridge the gap between scientific research and clinical application. Though currently ranked #264 out of 387 in the medicine category for cardiology and cardiovascular medicine, its commitment to quality and accessibility exemplifies the journal's importance in fostering collaboration and knowledge sharing within the medical community. Researchers are encouraged to take advantage of its open-access model to ensure that groundbreaking developments in cardiology are readily available to all stakeholders in the field.

Journal Of Cardiovascular and Thoracic Research

Innovative Research for a Healthier Heart
Publisher: TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICESISSN: 2008-5117Frequency: 4 issues/year

Journal of Cardiovascular and Thoracic Research is a premier open access journal published by Tabriz University of Medical Sciences & Health Services, focusing on the dynamic fields of cardiology and cardiovascular medicine. With an ISSN of 2008-5117 and E-ISSN 2008-6830, the journal provides a platform for innovative research and advances in cardiovascular and thoracic health, catering to a global audience of researchers, healthcare professionals, and students. Since its inception as an open access publication in 2010, the journal has established itself within the academic community, evidenced by its inclusion in Scopus and its category quartile ranking (Q3) in 2023. Located in Tabriz, Iran, the journal aims to disseminate high-quality studies that contribute to the understanding and treatment of cardiovascular diseases, thus enabling advancements in this critical field of medicine. With a Scopus rank of 248 out of 387 in the category of Cardiology and Cardiovascular Medicine, the Journal of Cardiovascular and Thoracic Research is dedicated to fostering collaboration and dialogue among researchers and practitioners, promoting a deeper understanding of cardiovascular and thoracic health.

Rational Pharmacotherapy in Cardiology

Enhancing Treatment Strategies with Cutting-Edge Research
Publisher: SOC CARDIOLOGY RUSSIAN FEDERATISSN: 1819-6446Frequency: 6 issues/year

Rational Pharmacotherapy in Cardiology, published by the SOC CARDIOLOGY RUSSIAN FEDERATION, stands as a crucial platform for advancing knowledge in the field of cardiology and pharmacology. Established as an Open Access journal in 2005, it allows for unrestricted access to research findings, fostering collaboration among researchers, clinicians, and students. The journal, with its ISSN 1819-6446 and E-ISSN 2225-3653, focuses on the intersection of rational pharmacotherapy and cardiovascular medicine, aiming to enhance treatment strategies and patient outcomes through evidence-based studies. Though currently positioned in the Q4 category in both cardiology and pharmacology rankings, its ongoing commitment to rigorous peer review and scholarly research ensures its relevance and growth in the scientific community. With a unique address in Moscow, Russia, the journal seeks to serve as a valuable resource for those dedicated to improving cardiovascular health and therapeutic practices worldwide, making it an essential read for professionals keen on the latest trends and discoveries in this vital area of medicine.

International Heart Journal

Advancing Cardiovascular Knowledge Globally
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Revista de la Federacion Argentina de Cardiologia

Elevating standards in cardiology one study at a time.
Publisher: FEDERACION ARGENTINA CARDIOLOGIAISSN: 0326-646XFrequency: 4 issues/year

Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.

Clinical Lymphoma Myeloma & Leukemia

Fostering Collaboration in Blood Cancer Science
Publisher: CIG MEDIA GROUP, LPISSN: 2152-2650Frequency: 6 issues/year

Clinical Lymphoma Myeloma & Leukemia is a prestigious journal dedicated to the study and treatment of hematologic malignancies, offering a vital platform for researchers and healthcare professionals in the fields of oncology, hematology, and cancer research. Published by CIG MEDIA GROUP, LP, this journal has established itself as a crucial resource since its inception in 2010, with a continuous commitment to disseminating knowledge until at least 2024. With an impact factor that objectively reflects its influence, it is rated in Q3 quartiles in both Cancer Research and Hematology as well as in Oncology as of 2023. Researchers can access a wealth of articles and studies that explore various dimensions of lymphoma, myeloma, and leukemia, thus fostering an environment of collaboration and innovation. Although it currently does not offer full open access, its extensive archive and rigorous peer-review process ensure the publication of high-quality research, making it an essential resource for anyone dedicated to advancing the science and practice of treating blood cancers.

THORACIC AND CARDIOVASCULAR SURGEON

Empowering professionals with essential surgical insights.
Publisher: GEORG THIEME VERLAG KGISSN: 0171-6425Frequency: 8 issues/year

THORACIC AND CARDIOVASCULAR SURGEON, published by GEORG THIEME VERLAG KG, is a prestigious journal dedicated to the fields of cardiology, cardiovascular surgery, and pulmonary medicine. Since its inception in 1973, the journal has served as a vital platform for disseminating cutting-edge research and innovative techniques, contributing significantly to advancements in patient care and surgical practices. With an emerging recognition evidenced by its category quartiles, ranking Q3 in Cardiology and Cardiovascular Medicine and Q2 in Surgery as of 2023, it positions itself as an essential resource for both clinicians and researchers alike. Although this journal does not currently offer Open Access options, it maintains a strong impact with Scopus rankings that highlight its relevance within the medicine and surgery disciplines. The journal is particularly committed to bridging the gap between theoretical research and practical application, making it crucial for professionals aiming to stay informed on the latest developments in thoracic and cardiovascular health. Join a community of scholars dedicated to excellence in these critical areas of medicine.

Netherlands Heart Journal

Advancing Cardiovascular Knowledge for a Healthier Tomorrow
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

KARDIOLOGIYA

Fostering Collaboration for Heart Health Advancements
Publisher: RUSSIAN HEART FAILURE SOCISSN: 0022-9040Frequency: 12 issues/year

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.

Cardiology Research

Unlocking the future of cardiovascular interventions.
Publisher: ELMER PRESS INCISSN: 1923-2829Frequency: 6 issues/year

Cardiology Research is a prominent open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by ELMER PRESS INC. Renowned for its rigorous peer-review process, the journal provides a platform for cutting-edge research and innovative clinical practices in cardiology. With an ISSN of 1923-2829 and an E-ISSN of 1923-2837, it has established an impactful presence in the academic community, achieving a 2023 Scopus quartile ranking of Q3 in its category, positioning it in the 41st percentile. The journal's scope encompasses various aspects of cardiology research, including but not limited to epidemiology, diagnostics, therapeutics, and cardiovascular interventions. Although it operates without open access in certain contexts, it provides flexible access options for readers, ensuring that its valuable insights are widely disseminated. Cardiology Research is an essential resource for researchers, healthcare professionals, and students who aspire to stay at the forefront of cardiovascular science, contributing significantly to the global discourse on heart health.